机构

• 上海药物研究所 [16]
• 地理科学与资源研究所 [3]
• 力学研究所 [1]
• 西北高原生物研究所 [1]
• 自动化研究所 [1]
• 新疆天文台 [1]
• 更多

采集方式

• OAI收割 [24]

内容类型

• 期刊论文 [24]

发表日期

• 2023 [24]

学科主题

• Engineerin... [1]
• Environmen... [1]
• Science & ... [1]

筛选

浏览/检索结果: 共24条，第1-10条 帮助 限定条件 发表日期：2023     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Discovery of Dual Function Agents That Exhibit Anticancer Activity via Catastrophic Nicotinamide Adenine Dinucleotide Depletion 期刊论文  OAI收割 JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 66, 期号: 24, 页码: 16694-16703 作者:  Fu, Yixian;  Huang, Yahui;  Zhou, Chenchen;  Li, Xinge;  Dong, Guoqiang   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/01/26 From bench to bedside: current development and emerging trend of KRAS-targeted therapy 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2023, 页码: 18 作者:  Chen, Yi;  Liu, Qiu-pei;  Xie, Hua;  Ding, Jian   |  收藏  |  浏览/下载：28/0  |  提交时间：2024/01/16 KRAS mutation  KRAS(G12C) inhibitor  Pan-KRAS inhibitor  SHP2 allosteric inhibitor  SOS1 inhibitor  combination therapy   Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma 期刊论文  OAI收割 ACTA PHARMACEUTICA SINICA B, 2023, 卷号: 13, 期号: 12, 页码: 4748-4764 作者:  Liu, Yingqiang;  Zhan, Zhengsheng;  Kang, Zhuang;  Li, Mengyuan;  Lv, Yongcong   |  收藏  |  浏览/下载：9/0  |  提交时间：2024/01/26 Small molecule inhibitor  Tumor microenvironment  Immune-checkpoint  immune-deficient mouse models  including temozolomide (TMZ) insensitive tumors. Notably   Stretchable Electronic Facial Masks for Skin Electroporation 期刊论文  OAI收割 ADVANCED FUNCTIONAL MATERIALS, 2023, 页码: 14 作者:  Xu XK(徐新凯);  Guo L(郭亮);  Liu, Hao;  Zhou ZX(周赞鑫);  Li, Shuang   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/01/01 conductive ink  conductive silicone  skin electroporation  stretchable electronics   Identification of [1,2,4]Triazolo[4,3-a]pyrazine PARP1 inhibitors with overcome acquired resistance activities 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 259, 页码: 19 作者:  Wang, Pingyuan;  Zhu, Wen-Ting;  Wang, Yajing;  Song, Shan-Shan;  Xi, Yong   |  收藏  |  浏览/下载：58/0  |  提交时间：2023/10/17 PARP1 inhibitor  Synthetic lethality  Drug resistance  Anticancer  Structure -activity relationship   Design and synthesis of 1H-pyrazolo[3,4-d]pyrimidine derivatives as hematopoietic progenitor kinase 1 (HPK1) inhibitors 期刊论文  OAI收割 BIOORGANIC CHEMISTRY, 2023, 卷号: 140, 页码: 18 作者:  Zhang, Junjie;  Li, Yan;  Tang, Haotian;  Zhou, Qianqian;  Tong, Linjiang   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/08 Cancer immunotherapy  HPK1  Structure -based design  HPK1 inhibitor   Tetrandrine synergizes with MAPK inhibitors in treating KRAS-mutant pancreatic ductal adenocarcinoma via collaboratively modulating the TRAIL-death receptor axis 期刊论文  OAI收割 PHARMACOLOGICAL RESEARCH, 2023, 卷号: 197, 页码: 12 作者:  Tang, Shuai;  Duan, Yichen   |  收藏  |  浏览/下载：8/0  |  提交时间：2023/12/11 KRAS  Pancreatic ductal adenocarcinoma  MAPK pathway  Tetrandrine  TRAIL  Death receptors   ProxyMix: Proxy-based Mixup training with label refinery for source-free domain adaptation 期刊论文  OAI收割 NEURAL NETWORKS, 2023, 卷号: 167, 页码: 92-103 作者:  Ding, Yuhe;  Sheng, Lijun;  Liang, Jian;  Zheng, Aihua;  He, Ran   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/11/16 Source-free unsupervised domain  adaptation  Pseudo labeling   Vegetation structural shift tells environmental changes on the Tibetan Plateau over 40 years 期刊论文  OAI收割 SCIENCE BULLETIN, 2023, 卷号: 68, 期号: 17, 页码: 1928-1937 作者:  Wang, Yanfen;  Xue, Kai;  Hu, Ronghai;  Ding, Boyang;  Zeng, Hong   |  收藏  |  浏览/下载：15/0  |  提交时间：2023/10/30 Vegetation structural shift  Climate change  The Tibetan Plateau  Vegetation map   Design, synthesis and pharmacological evaluation of 2,3-dihydrobenzo-furan IRAK4 inhibitors for the treatment of diffuse large B-cell lymphoma 期刊论文  OAI收割 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 卷号: 256, 页码: 16 作者:  Chen, Yun;  Ning, Yi;  Chen, Zhiwei;  Xue, Yaping;  Wu, Qingyun   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Apoptosis  Diffuse large B-Cell lymphoma  Interleukin-1 receptor associated kinase 4  Structure-based drug design  2  3-Dihydrobenzofuran